Preprint Article Version 1 Preserved in Portico This version is not peer-reviewed

HMGA2 Promotes Colorectal Cancer Angiogenesis via Dual Regulation of Sema3A and VEGFA

Version 1 : Received: 3 October 2021 / Approved: 20 October 2021 / Online: 20 October 2021 (11:25:53 CEST)

How to cite: Wang, C.; Long, Y.; Tao, M.; Ma, H.; Li, Y.; Zhou, G.; Hu, X.; Wang, W.; Liu, R.; Zhou, M.; Xu, G.; Wang, Z.; Chen, M.; Zhou, Q. HMGA2 Promotes Colorectal Cancer Angiogenesis via Dual Regulation of Sema3A and VEGFA. Preprints 2021, 2021100289 (doi: 10.20944/preprints202110.0289.v1). Wang, C.; Long, Y.; Tao, M.; Ma, H.; Li, Y.; Zhou, G.; Hu, X.; Wang, W.; Liu, R.; Zhou, M.; Xu, G.; Wang, Z.; Chen, M.; Zhou, Q. HMGA2 Promotes Colorectal Cancer Angiogenesis via Dual Regulation of Sema3A and VEGFA. Preprints 2021, 2021100289 (doi: 10.20944/preprints202110.0289.v1).

Abstract

Background: HMGA2 encodes a small non histone chromatin-associated protein that has no intrinsic transcriptional activity, but can modulate transcription by altering the chromatin architecture. HMGA2 was found overexpressed in a variety of epithelial and mesenchymal tumors and promoted invasion and metastasis in most malignant epithelial tumors. A recent study showed that P53 inhibited CRC progression by targeting HMGA2. However, the mechanism by which HMGA2 affect angiogenesis in CRC has not been clarified. Methods: The expression of HMGA2 was analyzed by IHC, WB and bio infomatic analysis. Cbioportal and mexpress online tools were applied to explore the CNV and methylation of HMGA2 in CRC patients. Single cell data from GEO was used to examine the specific cell type that contribute to the high HMGA2 expression in CRC. Lentivirus was used to knock down HMGA2 in CRC cells and HUVECs was used to study angiogenesis. Results: In the current study, we first detected the expression pattern of HMGA2 in CRC patients and evaluated its clinical values and CNV amplification could possibly contribute to the up regulation of HMGA2 in CRC patients. By analyzing CRC single cell data we found that HMGA2 was specifically up regulated in the colorectal epithelial cells. Furthermore, knocking down of HMGA2 suppresses angiogenesis via dual regulation of VEGF-A and SEMA3A in CRC through inactivating VEGRR2 pathway in HUVECs. Conclusions: HMGA2 might be a promising prognostic marker and target for treating advanced CRC patients.

Keywords

HMGA2; Colorectal cancer; Sema3A; VEGFA

Subject

MEDICINE & PHARMACOLOGY, Gastroenterology

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our diversity statement.

Leave a public comment
Send a private comment to the author(s)
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.